Titan Pharmaceuticals
TTNP
HK$31.55
Share price
-8.22%
Change (1 day)
-29.14%
Change (1 year)
Categories
Titan Pharmaceuticals (TTNP) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : HK$2.18 Million
According to Titan Pharmaceuticals 's latest financial reports the company's total liabilities are HK$2.18 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Titan Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | HK$11.27 M | -46.44% |
| 2022-12-31 | HK$21.05 M | -5.45% |
| 2021-12-31 | HK$22.26 M | -36.93% |
| 2020-12-31 | HK$35.31 M | -43.95% |
| 2019-12-31 | HK$62.99 M | 10.75% |
| 2018-12-31 | HK$56.88 M | -9.53% |
| 2017-12-31 | HK$62.87 M | 48.08% |
| 2016-12-31 | HK$42.46 M | -12.99% |
| 2015-12-31 | HK$48.8 M | -48.59% |
| 2014-12-31 | HK$94.93 M | -3.31% |
| 2013-12-31 | HK$98.19 M | -73.58% |
| 2012-12-31 | HK$0.37 B | 57.97% |
| 2011-12-31 | HK$0.23 B | 179.84% |
| 2010-12-31 | HK$84.08 M | 175.74% |
| 2009-12-31 | HK$30.49 M | |
| 2007-12-31 | HK$33.18 M | 25.71% |
| 2006-12-31 | HK$26.39 M | 8.56% |
| 2005-12-31 | HK$24.31 M | -14.79% |
| 2004-12-31 | HK$28.53 M | 10.19% |
| 2003-12-31 | HK$25.89 M | -15.82% |
| 2002-12-31 | HK$30.76 M | -31.55% |
| 2001-12-31 | HK$44.94 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Vanda Pharmaceuticals VNDA | HK$0.94 B | 43,096.77% | 🇺🇸 USA |
 MediciNova MNOV | HK$19.62 M | 796.30% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | HK$0.28 B | 12,978.85% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$907.08 B | 41,419,971.68% | 🇺🇸 USA |
 Novartis NVS | HK$482.64 B | 22,038,968.10% | 🇨🇭 Switzerland |
 Repligen
RGEN | HK$6.80 B | 310,530.82% | 🇺🇸 USA |